Jason Berman, University of Ottawa

Research

Bone Marrow Failure Leukemia Metabolomics Therapeutics Zebrafish

Latest papers

The impact of Down syndrome-specific non-malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease.
Cytometry. Part B, Clinical cytometry · 2023

All 1 publications

Latest funding

Dissecting the roles of the Polycomb protein MTF2 in leukemogenesis
CIHR · 2022 · Co-investigator
$956,250
Identifying novel strategies for leukemia prevention using zebrafish models of dnajc21-mutant Shwachman Diamond syndrome
CIHR · 2022 · Nominated PI
$910,350
Zebrafish tp53 Mutants Recapitulate Li-Fraumeni Syndrome Phenotypes and Provide a Preclinical Platform for Evaluating Tumor Preventive Compounds
CIHR · 2022 · Supervisor
$105,000

All 3 grants and awards

1 publications.

01

The impact of Down syndrome-specific non-malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease.

Hsu FC, Hudson C, Wilson ER, Pardo LM, Singleton TP, Xu D, Zehentner BK, Hitzler J, Berman J, Wells DA, Loken MR, Brodersen LE

Cytometry. Part B, Clinical cytometry2023

DOI: 10.1002/cyto.b.22118 PMID: 37015883

Dissecting the roles of the Polycomb protein MTF2 in leukemogenesis

Co-investigatorCIHR2022Project Grant

Principal investigators: Stanford, William L

Keywords: Acute Myeloid Leukemia (Aml); Chemoresistance; Chromatin Immunoprecipitation; Dna Damage Response; Epigenetics; Gene Regulatory Networks; Hematopoiesis; Transcriptomics

$956,250

Identifying novel strategies for leukemia prevention using zebrafish models of dnajc21-mutant Shwachman Diamond syndrome

Nominated PICIHR2022Project Grant

Principal investigators: Berman, Jason N

Keywords: Bone Marrow Failure; Leukemia; Metabolomics; Therapeutics; Zebrafish

$910,350

Zebrafish tp53 Mutants Recapitulate Li-Fraumeni Syndrome Phenotypes and Provide a Preclinical Platform for Evaluating Tumor Preventive Compounds

SupervisorCIHR2022Doctoral Research Award : Priority Announcement - Primary Prevention of Cancer

Principal investigators: Kobar, Kimberly

Keywords: Cancer; Drug Discovery; Genetic Models; Li-Fraumeni Syndrome; P53; Zebrafish

$105,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Johann Hitzler

Developmental and Stem Cell Biology

1 shared papers, latest 2023

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Bone Marrow Failure Dear Professor Berman, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The impact of Down syndrome-specific non-malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease." (2023), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Identifying novel strategies for leukemia prevention using zebrafish models of dnajc21-mutant Shwachman Diamond syndrome" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]